Daniel G. Wildman
DirectoratUroGen Pharma· In proxies 2023–2025
Daniel G. Wildman sits on 4 public boards.
Boards1
- UroGen PharmaDirector · 3 yr on the boardIndependentCompliance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- UroGen PharmaPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +323%
- Nyxoah S.A.Public company
- Director? – PresentNo stock prices for these years
- PanTher Therapeutics, IncPublic company
- Director? – PresentNo stock prices for these years
- Progenerative Medical, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?